On March 13, 2025, MEDIROM Healthcare Technologies Inc. announced that Yasuhiro Hayami, Chief Business Officer of its subsidiary, MEDIROM Mother Labs Inc., made a second investment in Mother Labs’ Series A financing.
This additional investment was made at a pre-money valuation of JPY 9 billion, approximately US$60 million as of March 13, 2025. Mr. Hayami's continued financial commitment follows his initial investment in December 2024.
The repeated investment from a senior executive underscores strong confidence in Mother Labs' corporate philosophy, vision, and future growth potential. This action further validates the subsidiary's strategic direction and the commercial prospects of its health-tech products.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.